fluvoxamine maleate tablet, coated
a-s medication solutions - fluvoxamine maleate (unii: 5lgn83g74v) (fluvoxamine - unii:o4l1xpo44w) - fluvoxamine maleate tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (ocd), as defined in dsm-iii-r or dsm-iv. the obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning. obsessive compulsive disorder is characterized by recurrent and persistent ideas, thoughts, impulses or images (obsessions) that are ego-dystonic and/or repetitive, purposeful, and intentional behaviors (compulsions) that are recognized by the person as excessive or unreasonable. the efficacy of fluvoxamine maleate tablets was established in four trials in outpatients with ocd: two 10-week trials in adults, one 10-week trial in pediatric patients (ages 8-17), and one maintenance trial in adults [see clinical studies (14)] . coadministration coadministration of tizanidine, thioridazine, alosetron, or pimozide with fluvoxamine maleate tablets is contraindicated [see warnings and precautions (5.4,
exjade
novartis pharmaceuticals australia pty ltd - deferasirox -
exjade 125 mg
novartis israel ltd - deferasirox - tablets dispersible - deferasirox 125 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusionalhaemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg/l).lic is the preferred method of iron overload determination and should be used wherever available
exjade 500 mg
novartis israel ltd - deferasirox - tablets dispersible - deferasirox 500 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusionalhaemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg/l).lic is the preferred method of iron overload determination and should be used wherever available
exjade 250 mg
novartis israel ltd - deferasirox - tablets dispersible - deferasirox 250 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusionalhaemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg/l).lic is the preferred method of iron overload determination and should be used wherever available
baclopar 10 milligram tablets
generics (uk) limited - baclofen - tablets - 10 milligram - other centrally acting agents
dyazide 50mg/25mg milligram tablets
mercury pharmaceuticals ltd - triamterene, hydrochlorothiazide - tablets - 50mg/25mg milligram - low-ceiling diuretics and potassium-sparing agents
furosemide bristol 20 mg tablets
bristol laboratories limited - furosemide - tablet - 20 milligram(s) - sulfonamides, plain; furosemide
furosemide bristol 40 mg tablets
bristol laboratories limited - furosemide - tablet - 40 milligram(s) - sulfonamides, plain; furosemide
leflunomide 10 mg film coated tablets
morningside healthcare limited - leflunomide - tablet - 10 milligram(s) - selective immunosuppressants; leflunomide